Cargando…
Ginsenoside Rg3 Sensitizes Colorectal Cancer to Radiotherapy through Downregulation of Proliferative and Angiogenic Biomarkers
BACKGROUND: Radiation therapy is an important mode of colorectal cancer treatment. However, most people die of local recurrence after tumors become resistant to radiotherapy, and little progress has been made in treating radiotherapy-resistant colorectal cancer. Hence, novel agents that are nontoxic...
Autores principales: | Liu, Taiguo, Duo, Lina, Duan, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5878898/ https://www.ncbi.nlm.nih.gov/pubmed/29743919 http://dx.doi.org/10.1155/2018/1580427 |
Ejemplares similares
-
Anti-Angiogenic Properties of Ginsenoside Rg3
por: Nakhjavani, Maryam, et al.
Publicado: (2020) -
Antitumor activity of ginsenoside Rg3 in melanoma through downregulation of the ERK and Akt pathways
por: Meng, Lingbin, et al.
Publicado: (2019) -
Anti-Angiogenic Properties of Ginsenoside Rg3 Epimers: In Vitro Assessment of Single and Combination Treatments
por: Nakhjavani, Maryam, et al.
Publicado: (2021) -
Ginsenoside Rg2 inhibits osteoclastogenesis by downregulating the NFATc1, c-Fos, and MAPK pathways
por: Lee, Sung-Hoon, et al.
Publicado: (2023) -
Pharmacological activities of ginsenoside Rg5 (Review)
por: Liu, Ming-Yang, et al.
Publicado: (2021)